Valuation: ApicHope Pharmaceutical Group Co., Ltd.

Market Cap 17.04B 2.52B 2.18B 2.04B 1.87B 3.52B 240B 3.58B 23.93B 9.39B 120B 9.48B 9.27B 398B P/E 2026 *
32.8x
P/E 2027 * -165x
Enterprise Value 17.04B 2.52B 2.18B 2.04B 1.87B 3.52B 240B 3.58B 23.93B 9.39B 120B 9.48B 9.27B 398B EV / Sales 2026 *
15.8x
EV / Sales 2027 * 13.5x
Free-Float
31.84%
Yield 2026 *
-
Yield 2027 * -
1 day+4.20%
1 week+7.62%
Current month+7.62%
1 month+0.80%
3 months-7.00%
6 months+12.13%
Current year+13.23%
1 week 34.78
Extreme 34.78
38.38
1 month 33.41
Extreme 33.41
43.5
Current year 29.31
Extreme 29.31
45.88
1 year 29.31
Extreme 29.31
76.88
3 years 12.74
Extreme 12.74
81.48
5 years 12.74
Extreme 12.74
81.48
10 years 7.58
Extreme 7.577775
81.48
Manager TitleAgeSince
Chief Executive Officer 52 11/11/2015
Director of Finance/CFO 60 11/11/2015
Investor Relations Contact 38 31/12/2020
Director TitleAgeSince
Director/Board Member 70 01/07/2024
Chairman 52 11/11/2015
Director/Board Member 58 11/11/2015
Date Insider Type Main position Quantity % Market Cap.
05/01/26 Buy

Director

4,200 0.0010%
24/11/25 Buy

Director

7,000 0.0017%
01/09/23 Buy 20,000 0.0089%
Change 5-day change 1-year change 3-year change Capi.($)
+4.20%+7.62%-44.14%+92.65% 2.52B
-0.31%-2.29%+22.57%+69.33% 49.03B
+4.40%+14.46%+62.66%+133.25% 42.33B
-0.89%-0.64%-1.48%+15.58% 12.43B
+0.56%-1.12%+19.02%+70.02% 11.68B
+0.19%+0.77%+31.74%+141.01% 9.12B
+1.99%+4.41%+17.56%+34.79% 7.15B
+1.82%-0.15%+39.41%-13.77% 7.09B
+0.40%+2.02%+12.85%+176.30% 6.76B
+6.44%+8.26%-24.61%+30.64% 5.95B
Average +1.88%+3.29%+13.56%+74.98% 15.41B
Weighted average by Cap. +1.60%+3.83%+29.12%+85.00%

Financials

2026 *2027 *
Net sales 1.08B 160M 138M 129M 119M 223M 15.23B 227M 1.52B 595M 7.63B 601M 588M 25.24B 1.26B 186M 161M 151M 138M 260M 17.74B 264M 1.77B 693M 8.89B 700M 685M 29.4B
Net income 526M 77.94M 67.42M 62.96M 57.76M 109M 7.42B 110M 739M 290M 3.72B 293M 286M 12.29B -102M -15.11M -13.07M -12.21M -11.2M -21.07M -1.44B -21.4M -143M -56.22M -721M -56.76M -55.51M -2.38B
Net Debt - -
Logo ApicHope Pharmaceutical Group Co., Ltd.
ApicHope Pharmaceutical Group Co Ltd is a China-based company primarily engaged in the research and development, production and sales of pharmaceuticals. The Company mainly focuses on the fields of pediatrics drug and chronic disease drug, and its product categories cover chemical medicine (including raw materials and preparations), special Chinese patent medicine, biological vaccines and other fields. The Company’s paediatric drugs are used to treat common diseases, such as children's influenza, colds, infectious diseases, functional dyspepsia and others. The Company’s chronic disease drugs are used for treatment of cardiovascular and cerebrovascular diseases, kidney diseases, digestive system diseases, liver diseases and other diseases. The Company’s main products include Fuganlin oral liquid, clindamycin hydrochloride palmitate dispersible tablets and other products. The Company mainly conducts its business in the domestic market.
Employees
1,294
Date Price Change Volume
07/08/26 CN¥37.99 +4.20% 16,250,319
06/08/26 CN¥36.46 +0.66% 12,081,814
05/08/26 CN¥36.22 +1.66% 9,764,467
04/08/26 CN¥35.63 +1.57% 8,693,020
03/08/26 CN¥35.08 -0.62% 6,332,590

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 300723 Stock